'''Spirorenone''' ([[International Nonproprietary Name|INN]]) (developmental code name '''ZK-35973''') is a [[steroid]]al [[antimineralocorticoid]] of the [[spirolactone]] group that was never marketed.<ref name="Elks2014">{{cite book|author=J. Elks|title=The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies|url=https://books.google.com/books?id=0vXTBwAAQBAJ&pg=PA1112|date=14 November 2014|publisher=Springer|isbn=978-1-4757-2085-3|pages=1112–}}</ref><ref name="MortonHall2012">{{cite book|author1=I.K. Morton|author2=Judith M. Hall|title=Concise Dictionary of Pharmacological Agents: Properties and Synonyms|url=https://books.google.com/books?id=tsjrCAAAQBAJ&pg=PA106|date=6 December 2012|publisher=Springer Science & Business Media|isbn=978-94-011-4439-1|pages=106–}}</ref> Spirorenone possesses 5–8 times the antimineralocorticoid activity of [[spironolactone]] in animal studies.<ref name="JamesPasqualini2013">{{cite book|author1=V. H. T. James|author2=J. R. Pasqualini|title=Hormonal Steroids: Proceedings of the Sixth International Congress on Hormonal Steroids|url=https://books.google.com/books?id=1VMJAwAAQBAJ&pg=PA776|date=22 October 2013|publisher=Elsevier Science|isbn=978-1-4831-9067-9|pages=776–}}</ref> The initial discovery of spirorenone was deemed a great success, as no compound with greater antimineralocorticoid activity had been developed since spironolactone in 1957.<ref name="IUPACFischer2006">{{cite book|author1=IUPAC|author2=Janos Fischer|author3=C. Robin Ganellin|title=Analogue-based Drug Discovery|url=https://books.google.com/books?id=FjKfqkaKkAAC&pg=PA396|date=13 December 2006|publisher=John Wiley & Sons|isbn=978-3-527-60749-5|pages=396–}}</ref> Moreover, spirorenone itself has virtually no [[affinity (pharmacology)|affinity]] for the [[androgen receptor]] while its [[progestogen]]ic activity shows species differences, being somewhat greater than that of spironolactone in rabbits but absent in mice and rats.<ref name="JamesPasqualini2013" /> As such, it was characterized as a highly potent antimineralocorticoid with far fewer hormonal side effects relative to spironolactone.<ref name="IUPACFischer2006" />
